Bauchspeicheldrüsen-Krebsorganoid, Phänotyp „TEBBO“. Forschung im Team von Prof. Dr. Maximilian Reichert, für Translationale Pankreaskarzinomforschung an der TUM.
ENGLISH VERSION. Pancreatic tumor organoid, phenotype “TEBBO”.
Verwendung frei für die Berichterstattung über die TUM im Kontext der Studie "„Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma”; Nature Biomedical Engineering (2024); DOI https://10.1038/s41551-024-01273-9 bei Nennung des Copyrights / Free for use in reporting on TUM in the context of the project "„Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma”; Nature Biomedical Engineering (2024); DOI https://10.1038/s41551-024-01273-9" with the copyright noted